aldosterone has been researched along with trandolapril in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianco, L; Caravaggi, M; Crema, A; D'Angelo, L; De Ponti, F; Frigo, GM; Lecchini, S; Marelli, C | 1 |
| Gray, JM; Paster, R; Saunders, E; Weir, MR | 1 |
| Saunders, E; Weir, MR | 1 |
| Bartels, GL; de Leeuw, PW; Remme, WJ; van der Ent, M | 1 |
| Connell, JM; Donnelly, R; Elliott, HL; Morris, AD; Petrie, JR; Small, M; Ueda, S | 1 |
| Bongrani, S; Cargnioni, A; Ferrari, R; Gitti, GL; Pasini, E; Pastore, F; Razzetti, R | 1 |
| Fujita, T; Goto, A; Kobayashi, N; Matsuoka, H; Onozato, ML; Tojo, A | 1 |
| Ahuja, K; Go, C; Jorde, UP; Kasper, M; Tseng, CH; Turalic, H; Vittorio, TJ | 1 |
| Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A | 1 |
4 trial(s) available for aldosterone and trandolapril
| Article | Year |
|---|---|
Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Radioimmunoassay; Renin; White People | 1995 |
Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans. Trandolapril Multicenter Study Group.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin; Treatment Outcome | 1998 |
Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Glucose; Glucose Clamp Technique; Heart Rate; Humans; Hyperinsulinism; Hypertension; Indoles; Insulin; Male; Middle Aged; Peptidyl-Dipeptidase A; Placebos; Renin | 2000 |
Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Heart Failure; Humans; Indoles; Male; Middle Aged | 2007 |
5 other study(ies) available for aldosterone and trandolapril
| Article | Year |
|---|---|
Pharmacological activity and safety of trandolapril (RU 44570) in healthy volunteers.
Topics: Adult; Aldosterone; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Hemodynamics; Humans; Indoles; Male; Peptidyl-Dipeptidase A; Renin | 1991 |
Renal hemodynamic effects in patients with moderate to severe heart failure during chronic treatment with trandolapril.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Digoxin; Diuretics; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Indoles; Kidney; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Pulmonary Wedge Pressure; Renal Circulation; Renin; Time Factors | 1998 |
Effect of nolomirole on monocrotaline-induced heart failure.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Aldosterone; Animals; Ascitic Fluid; Atrial Natriuretic Factor; Body Weight; Disease Models, Animal; Dopamine Agonists; Drug Evaluation, Preclinical; Esters; Female; Heart Atria; Heart Failure; Heart Ventricles; Hypertrophy, Right Ventricular; Indoles; Monocrotaline; Norepinephrine; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes | 2004 |
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Drug Synergism; Eplerenone; Hypertension; Indoles; Kidney; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Spironolactone; Superoxide Dismutase; Transforming Growth Factor beta | 2007 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System | 2010 |